Health
Synthetic lung organoids provide high-throughput platform to identify new cellular targets of SARS-CoV-2 – News-Medical.Net
An interesting new study published on the bioRxiv preprint server describes a new platform that allows a high-throughput workflow to generate matched human lung…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that caused the coronavirus disease 2019 (COVID-19) pandemic, is still spreading and mutating. Scientists are working on therapeutics to control the virus. An interesting new study published on the bioRxiv* preprint server describes a new platform that allows a high-throughput workflow to generate matched human lung buds in the tens of thousands. This allows researchers to study SARS-CoV-2 infection and therapeutics in lung…
-
Business22 hours ago
Why the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours ago
Queensland weather forecast sees sunny weather for last week of winter
-
Business23 hours ago
Does Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours ago
Migrants raise concerns over Australia’s English tests for visa applicants